Although further investigation of the mechanisms by which Crp3 expression affects AAA, therapeutic modulation of Crp3 might serve to attenuate inflammation and media layer degeneration, therefore preventing the progression and rupture of abdominal aortic aneurysms. The gene discussed is CSRP3; the disease is triple-A syndrome.